Stay updated on Venetoclax and Novel Agents in AML Clinical Trial
Sign up to get notified when there's something new on the Venetoclax and Novel Agents in AML Clinical Trial page.

Latest updates to the Venetoclax and Novel Agents in AML Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedA new version entry (v3.6.0) and related items were added to the study record history, including 'Check who can join', 'Find Contact Information', and 'Study Status'. The previous revision entry (v3.5.5) was removed.SummaryDifference1%

- Check21 days agoChange DetectedThe history shows a new revision label v3.5.5, replacing the previous v3.5.4, indicating a recent update to the page's underlying build.SummaryDifference0.1%

- Check42 days agoChange DetectedRevision updated from v3.5.3 to v3.5.4 in the page history. This indicates a new version of the study record page.SummaryDifference0.1%

- Check64 days agoChange DetectedThe page now displays an updated ClinicalTrials.gov interface revision version (v3.5.3 instead of v3.5.2). This represents a site/version update rather than a change to the underlying study record.SummaryDifference0.1%

- Check71 days agoChange DetectedRevision: v3.5.2 was added and Revision: v3.5.0 was removed.SummaryDifference0.1%

- Check100 days agoChange DetectedThe history adds a new site revision entry (v3.5.0) and removes an older entry (v3.4.3). This reflects a software update and does not alter trial data or content.SummaryDifference0.1%

Stay in the know with updates to Venetoclax and Novel Agents in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Venetoclax and Novel Agents in AML Clinical Trial page.